RESEARCH NOTE--REVIEW OF CORRECTIONS-BASED THERAPY FOR OPIATE-DEPENDENT PATIENTS: IMPLICATIONS FOR BUPRENORPHINE TREATMENT AMONG CORRECTIONAL POPULATIONS.

Inmates with a history of opiate dependence represent a substantial proportion of the correctional population in the United States. Opiate use has negative consequences for both the inmate and society, including increased recidivism rates, increased infectious disease prevalence, avoidable emergency room use, decreased access to primary care services, and overdose. While there have been great successes in community-based treatment of opiate' dependence, these successes have not yet been achieved in correctional settings. This paper reviews the pharmacological treatment options for opiate-dependent inmates, along with potential application for community-to-correctional approaches. The recent approval by the Food and Drug Administration (FDA) of physician-prescribed buprenorphine and the new opportunities it presents to' corrections-based treatment are also explored in depth. Successful implementation of such strategies is likely to result in desirable health and social outcomes for both the inmate and the community at large. [ABSTRACT FROM AUTHOR]